Abstract
BackgroundTargeting regulatory T cell (Treg) infiltration is an emerging strategy for cancer immunotherapy. However, its efficacy in advanced prostate cancer remains unclear. Here, we showed the therapeutic efficacy of anti-Treg...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have